North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
The North America pharmaceutical drug delivery market is anticipated to reach US$ 936,148.9 Mn by 2027 from US$ 560,491.5 Mn in 2019. The market is projected to grow at a CAGR of 6.8% during 2020–2027.
The growth of the market in this region is primarily ascribed to the increasing prevalence of chronic diseases. On the other hand, the high cost of developing drug delivery devices hinders the market growth. On the other hand, increasing spending in the R&D related to drug delivery devices is expected to fuel the growth of the North American pharmaceutical drug delivery market in the coming years. Pharmaceutical and medical devices companies are focusing on R&D to develop new molecules for various therapeutic applications and drug delivery platforms. They invest majorly on R&Ds with an aim to deliver high-quality and innovative products. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies increased from US$ 49.6 billion 2012 to US$ 58.8 billion in 2015. Evonik Corporation has invested more than US$ 50 million over the last 4 years to advance its competencies in the medical devices market as well as in the marketplace for RESOMER polymers for drug delivery and bioreabsorbable medical devices.
Additionally, the companies are engaged in establishing new collaborations and partnerships for the development of new drug delivery systems. For instance, in December 2018, IntelGenx Corp., a leading oral drug delivery company, entered into a strategic collaboration with Gensco Pharma for the commercialization of RIZAPORT in the US. The newly approved device would be the first oral thin film to be used in the treatment of migraines. In April 2020, Revive Therapeutics announced research partnership with the University of Wisconsin-Madison to develop novel formulations and drug delivery technologies.
In 2019, the US accounted for the largest share in North America pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The US is an economically advanced country, and it leverages the presence of various well-established pharmaceutical market players. Increasing prevalence of chronic diseases such as diabetes and asthma, growing number of product launches by key players, and increasing use of drug delivery devices for disease management are among the key factors driving the country toward the largest market share.
US Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)
Get more information on this report :
NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
- North America
- US
- Canada
- Mexico
Company Profiles
- 3M
- Antares Pharma
- BD
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Pharmaceutical Drug Delivery Market – By Route of Administration
1.3.2 North America Pharmaceutical Drug Delivery Market – By Application
1.3.3 North America Pharmaceutical Drug Delivery Market – By End User
1.3.4 North America Pharmaceutical Drug Delivery Market – By Country
2. North America Pharmaceutical Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Pharmaceutical Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 4.2.1 North America Pharmaceutical Drug Delivery Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Pharmaceutical Drug Delivery Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.2 Key Restraints
5.2.1 High Cost of Drug Delivery Device Development
5.3 Key Market Opportunities
5.3.1 Increasing R&D Spending for Drug Delivery Devices
5.4 Future Trend
5.4.1 Growth in Drug Delivery Technology and Innovations
5.5 Impact Analysis
6. Pharmaceutical Drug Delivery Market – North America Analysis
6.1 North America Pharmaceutical Drug Delivery Market Revenue Forecasts and Analysis
6.2 Market Positioning of Key Players
7. Pharmaceutical Drug Delivery Market Analysis – By Route of Administration
7.1 Overview
7.2 North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
7.3 Oral Drug Delivery
7.3.1 Overview
7.3.2 Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Injectable Drug Delivery
7.4.1 Overview
7.4.2 Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Ocular Drug Delivery
7.6.1 Overview
7.6.2 Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Pulmonary Drug Delivery
7.7.1 Overview
7.7.2 Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Nasal Drug Delivery
7.8.1 Overview
7.8.2 Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Transmucosal Drug Delivery
7.9.1 Overview
7.9.2 Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.10 Implantable Drug Delivery
7.10.1 Overview
7.10.2 Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Drug Delivery Market Analysis – By Application
8.1 Overview
8.2 North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Cancer
8.4.1 Overview
8.4.2 Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Cardiovascular Diseases
8.5.1 Overview
8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Diabetes
8.6.1 Overview
8.6.2 Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Respiratory Diseases
8.7.1 Overview
8.7.2 Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Central Nervous System Disorders
8.8.1 Overview
8.8.2 Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Autoimmune Diseases
8.9.1 Overview
8.9.2 Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Other Diseases
8.10.1 Overview
8.10.2 Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Pharmaceutical Drug Delivery Market Analysis – By End User
9.1 Overview
9.2 North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 ASCs/ Clinics
9.5.1 Overview
9.5.2 ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 3M
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Antares Pharma
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 BD
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson & Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Drug Delivery Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Pharmaceutical Drug Delivery Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Pharmaceutical Drug Delivery Market
LIST OF FIGURES
Figure 1. Pharmaceutical Drug Delivery Market Segmentation
Figure 2. North America Pharmaceutical Drug Delivery Market Overview
Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pharmaceutical Drug Delivery Market
Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Pharmaceutical Drug Delivery Market- Leading Country Markets (US$ Mn)
Figure 6. North America Pharmaceutical Drug Delivery Market, Industry Landscape
Figure 7. North America Pharmaceutical Drug Delivery Market - North America PEST Analysis
Figure 8. Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. North America Pharmaceutical Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Market Positioning Of Key Players In Global Pharmaceutical Drug Delivery Market
Figure 11. North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 12. Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
Figure 21. Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)
Figure 30. Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. North America: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. North America Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 36. North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 37. US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Pharmaceutical Drug Delivery Market
- 3M
- Antares Pharma
- BD
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America pharmaceutical drug delivery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.